1. Home
  2. TMCI vs RAPP Comparison

TMCI vs RAPP Comparison

Compare TMCI & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMCI
  • RAPP
  • Stock Information
  • Founded
  • TMCI 2014
  • RAPP 2022
  • Country
  • TMCI United States
  • RAPP United States
  • Employees
  • TMCI N/A
  • RAPP N/A
  • Industry
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RAPP
  • Sector
  • TMCI Health Care
  • RAPP
  • Exchange
  • TMCI Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • TMCI 516.6M
  • RAPP 463.8M
  • IPO Year
  • TMCI 2021
  • RAPP 2024
  • Fundamental
  • Price
  • TMCI $6.45
  • RAPP $10.15
  • Analyst Decision
  • TMCI Hold
  • RAPP Strong Buy
  • Analyst Count
  • TMCI 8
  • RAPP 5
  • Target Price
  • TMCI $8.79
  • RAPP $35.00
  • AVG Volume (30 Days)
  • TMCI 365.9K
  • RAPP 259.3K
  • Earning Date
  • TMCI 05-06-2025
  • RAPP 05-10-2025
  • Dividend Yield
  • TMCI N/A
  • RAPP N/A
  • EPS Growth
  • TMCI N/A
  • RAPP N/A
  • EPS
  • TMCI N/A
  • RAPP N/A
  • Revenue
  • TMCI $209,357,000.00
  • RAPP N/A
  • Revenue This Year
  • TMCI $10.85
  • RAPP N/A
  • Revenue Next Year
  • TMCI $10.07
  • RAPP N/A
  • P/E Ratio
  • TMCI N/A
  • RAPP N/A
  • Revenue Growth
  • TMCI 11.88
  • RAPP N/A
  • 52 Week Low
  • TMCI $3.92
  • RAPP $6.43
  • 52 Week High
  • TMCI $11.83
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • TMCI 26.20
  • RAPP N/A
  • Support Level
  • TMCI $6.39
  • RAPP N/A
  • Resistance Level
  • TMCI $8.13
  • RAPP N/A
  • Average True Range (ATR)
  • TMCI 0.56
  • RAPP 0.00
  • MACD
  • TMCI -0.11
  • RAPP 0.00
  • Stochastic Oscillator
  • TMCI 2.77
  • RAPP 0.00

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: